Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2007-1-31
pubmed:abstractText
The hepatitis C virus (HCV) non-structural (NS)5A protein is linked to interferon alpha resistance in vitro and higher numbers of NS5A amino acid (aa) variations in HCV 1a/b isolates are associated with virologic response to interferon alpha-based therapy in vivo. Here, we aimed to study NS5A aa variations in Indian patients undergoing interferon alpha/ribavirin treatment infected with HCV 3a. The NS5A region [aa 2194-2401, comprising interferon sensitivity determining region, protein kinase resource (PKR) binding domain, V3 region] was sequenced from pre-treatment sera of 24 patients with HCV 3a infection. Mean number and physicochemical properties of aa variations (conserved vs. non-conserved) were assessed. Additionally, published NS5A sequences [NS5A region (n = 61), PKR binding domain (n = 111)] of characterized HCV 3a isolates were analyzed. The mean number of NS5A aa variations was not correlated with treatment response in our cohort. When all available NS5A sequences were included, a higher number of non-conserved aa variations within PKR binding domain and an extended V3 region of NS5A was associated with virologic response (P = 0.004 and 0.05, respectively). Mutational analyses of a large number of NS5A sequences suggest, that a higher number of non-conserved aa variations within the PKR binding domain and the extended V3 region is correlated with virologic response in HCV 3a infected patients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0300-8584
pubmed:author
pubmed:issnType
Print
pubmed:volume
196
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
11-21
pubmed:meshHeading
pubmed-meshheading:16955308-Adult, pubmed-meshheading:16955308-Amino Acid Sequence, pubmed-meshheading:16955308-Antiviral Agents, pubmed-meshheading:16955308-Cohort Studies, pubmed-meshheading:16955308-Drug Resistance, Viral, pubmed-meshheading:16955308-Female, pubmed-meshheading:16955308-Hepacivirus, pubmed-meshheading:16955308-Hepatitis C, Chronic, pubmed-meshheading:16955308-Hepatitis C Antigens, pubmed-meshheading:16955308-Humans, pubmed-meshheading:16955308-India, pubmed-meshheading:16955308-Interferon-alpha, pubmed-meshheading:16955308-Male, pubmed-meshheading:16955308-Middle Aged, pubmed-meshheading:16955308-Molecular Sequence Data, pubmed-meshheading:16955308-Mutation, pubmed-meshheading:16955308-Protein Structure, Secondary, pubmed-meshheading:16955308-Ribavirin, pubmed-meshheading:16955308-Sequence Alignment, pubmed-meshheading:16955308-Viral Nonstructural Proteins
pubmed:year
2007
pubmed:articleTitle
The hepatitis C virus NS5A protein and response to interferon alpha: mutational analyses in patients with chronic HCV genotype 3a infection from India.
pubmed:affiliation
Department of Gastroenterology, G.B. Pant Hospital, University of Delhi, New Delhi, India.
pubmed:publicationType
Journal Article